We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+7.89%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$169M
AUM Growth
+$6.16M
(+3.8%)
Cap. Flow
-$15.9M
Cap. Flow
% of AUM
-9.4%
Top 10 Holdings %
Top 10 Hldgs %
30.18%
Holding
221
New
53
Increased
41
Reduced
35
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMBM
Cambium Networks
CMBM
|
+$2.89M |
| 2 |
indie Semiconductor
INDI
|
+$2.88M |
| 3 |
Aspen Aerogels
ASPN
|
+$2.86M |
| 4 |
SCPH
scPharmaceuticals
SCPH
|
+$2.68M |
| 5 |
Biodesix
BDSX
|
+$2.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
+$7.12M |
| 2 |
Materion
MTRN
|
+$4.81M |
| 3 |
SEV
Sono Group N.V. Common Shares
SEV
|
+$2.22M |
| 4 |
Silicon Motion
SIMO
|
+$1.88M |
| 5 |
TechTarget
TTGT
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.73% |
| 2 | Healthcare | 21.33% |
| 3 | Financials | 6.11% |
| 4 | Industrials | 3.63% |
| 5 | Real Estate | 3.1% |
Similar funds
VL
WTG
QCA
SP
OGC
PE
RL
AIIC
Worth Venture Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Worth Venture Partners held 221 positions worth $169M, up 3.8% from $163M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Worth Venture Partners withdrew a net $15.9M in Q4 2022, closing 49 positions and reducing 35 holdings. Its most notable exit was Materion, an estimated $4.81M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Worth Venture Partners opened a new position in Cambium Networks worth $3.11M.
- Worth Venture Partners's largest Q4 2022 buy was Cambium Networks: 143,499 shares worth $3.11M.
- Worth Venture Partners added most to indie Semiconductor in Q4 2022, an estimated $2.88M increase.
- Worth Venture Partners's biggest Q4 2022 reduction was AVEO Pharmaceuticals, Inc., cutting an estimated $7.12M.
- Worth Venture Partners fully exited Materion in Q4 2022, selling an estimated $4.81M.
- Worth Venture Partners's ten largest holdings make up 30% of its $169M portfolio in Q4 2022.
- Worth Venture Partners opened 53 new positions and closed 49 in Q4 2022.
- Worth Venture Partners's portfolio value rose 3.8% quarter-over-quarter to $169M.
Based on Worth Venture Partners's 13F filing for Q4 2022, filed 14 Feb 2023.